無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医用画像管理の世界市場:考察・機会・分析・市場シェア・予測

Global Medical Image Management Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 423713
出版日 ページ情報 英文 140 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=109.71円で換算しております。
Back to Top
医用画像管理の世界市場:考察・機会・分析・市場シェア・予測 Global Medical Image Management Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022
出版日: 2017年01月18日 ページ情報: 英文 140 Pages
概要

当レポートでは、世界の医用画像管理の市場について分析し、全体的な市場構造・背景事情や影響要因、市場全体およびエンドユーザー別・製品別・地域別の市場動向見通し (過去3年間・今後6年間分)、昨今の資本取引・事業協定の動き、主要企業のプロファイル・事業戦略などについて調査しております。

第1章 イントロダクション

第2章 市場概要

  • 世界の医用画像管理市場:沿革と展望
  • 産業構造
  • 製造工程
  • 規制体制
  • 市場の全体的分析
  • 推計分析
  • 戦略分析
  • 競争分析
  • 戦略提言と主な結論

第3章 市場の決定要因

  • 市場促進要因と市場への影響度
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第4章 市場区分

  • 世界の医用画像管理市場:エンドユーザー別
    • 市場の定義と範囲
    • 意思決定データベースと推計手法
    • 市場部門別の比較分析
    • 市場機会のマトリックス
    • エンドユーザー別の市場区分
  • 世界の医用画像管理市場:製品別
    • 製品別の市場区分

第5章 比較分析

  • 主要な戦略
    • 企業合併・買収 (M&A) の一覧
    • 合弁事業 (JV) の一覧
    • 製品開発の一覧
    • 事業提携の一覧
  • 大手企業10社の分析

第6章 地域分類

  • 意思決定データベースと推計方法
  • 地域区分別の比較分析
  • 市場機会のマトリックス
  • 医用画像管理市場の動向見通し:地域別 (金額ベース、通算9年間分)
    • 北米市場
    • 欧州市場 (英国、フランス、ドイツ、イタリアなど)
    • アジア太平洋地域市場 (中国、インド、日本、韓国など)
    • 他の国々 (RoW) の市場 (ラテンアメリカ、中東・アフリカ)

第7章 企業プロファイル

目次
Product Code: HHE-4470117

The medical image management market is expected to grow with the CAGR of 6.8% during the forecasted period. The growing geriatric population across the globe is creating huge opportunities for medical image management market. In the US, the population aged 65 years or over is 15% in 2015 and it is expected to grow by 24% in near future. Likewise, Europe & Asia Pacific is also facing a challenge of growing geriatric population. Thus, rising geriatric population increases the demand for medical care which ultimately leads the demand for medical image management solutions such as PACS & VNA across geographies. The PACS (Picture archiving and communications systems) are highly used in the clinics and hospitals. The increasing demand is expected to expand investment in the medical image management system market. More factors such as innovations in image management solutions, government support to encourage EMR adoption are driving the demand of the medical image management market. There are some negative factors that hampering the market growth like budgetary constraints and concerns in post implementation of VNA solutions. The market has high capabilities in near future with the rising adoption of PACS & VNA and combination of VNA/PACS with ECM & EMR. The challenges in the market are lack of trained staff to maintain VNA solutions and strict adherence of VNA to open industry standards such as HL-7 & DICOM. The market has been segmented into four major regions such as North America, Europe, Asia Pacific & RoW. Presently, North America holds the largest market share due to high awareness among people of US and Canada about early detection of diseases and high innovations in the healthcare sector in the region. Asia Pacific is also a major region of the market, increasing due to growing maturity among people regarding adoption of new healthcare IT technologies in hospitals, small clinics, etc. The availability of large number of companies which is included in the report such as General electric, Siemens, IBM Corporation and so on are actively performing in the market by using innovations, mergers & acquisitions and partnership.

The medical image management market is segmented on the basis of end user and product. Amongst end user segment, the market is further sub-segmented into diagnostic imaging centers, hospitals and other end users such as contract research organizations, small clinics, etc. According to product, the market is further segmented into Picture archiving & communication system (PACS), Vendor neutral archives (VNA) and Application-independent Clinical archive (AICA). PACS is again sub-segmented into enterprise PACS and departmental PACS. The departmental PACS is further segmented into cardiology PACS and Radiology PACS and other departmental PACS. The Vendor neutral archives are again further segmented into procurement model and delivery model. The procurement model is again further segmented into Multi-departmental Enterprise VNA, Multi-site enterprise VNA and Departmental VNA. The delivery model is segmented into Hybrid VNA, On-Premise and Fully Cloud-Based VNA.

In the end user segment, Hospital held the largest share in 2015 with growth in EMR adoption. EMR adoption is supported by the HITECH Act (The Health Information Technology for Economic and Clinical Health) which is leading the demand for EMR & HR systems in the hospitals. In the product segment, PACS holds the largest share in 2016 with the increasing use of PACS in the novel imaging segments like oncology, mammography, endoscopy and ophthalmology.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. MARKET SCOPE

2. MARKET OVERVIEW

  • 2.1. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET: EVOLUTION & TRANSITION
  • 2.2. INDUSTRY STRUCTURE
  • 2.3. MANUFACTURING PROCESS
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
    • 2.7.6. GAP ANALYSIS
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. MARKET SHARE ANALYSIS
    • 2.8.2. TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISING USAGE OF IMAGE MANAGEMENT SYSTEMS BY IMAGING CENTERS
    • 3.1.2. INNOVATIONS IN IMAGE MANAGEMENT SOLUTIONS
    • 3.1.3. GOVERNMENT SUPPORT FOR ENCOURAGING EMR ADOPTION
    • 3.1.4. RISING INVESTMENT IN HEALTHCARE IT TECHNOLOGIES.
    • 3.1.5. GROWTH IN CLOUD BASED SOLUTIONS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. BUDGETARY CONSTRAINTS
    • 3.2.2. CONCERNS IN POST IMPLEMENTATION OF VNA SOLUTIONS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. COMBINATION OF VNA/PACS WITH ECM & EMR
    • 3.3.2. RISING ADOPTION OF PACS AND VNA
  • 3.4. MARKET CHALLENGES
    • 3.4.1. LACK OF TRAINED STAFF TO MAINTAIN VNA SOLUTIONS
    • 3.4.2. STRICT ADHERENCE OF VNA TO OPEN INDUSTRY STANDARDS SUCH AS HL-7 & DICOM

4. MARKET SEGMENTATION

  • 4.1. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY END USER
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION BY END USER 2014-2022 ($ MILLION)
      • 4.1.5.1. DIAGNOSTIC IMAGING CENTERS
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
        • 4.1.5.1.3. APPLICATION
        • 4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
        • 4.1.5.1.6. KEY CONCLUSIONS
      • 4.1.5.2. HOSPITALS
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
        • 4.1.5.2.3. APPLICATION
        • 4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
        • 4.1.5.2.6. KEY CONCLUSIONS
      • 4.1.5.3. OTHER END USERS
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
        • 4.1.5.3.3. APPLICATION
        • 4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.1.5.3.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
        • 4.1.5.3.6. KEY CONCLUSIONS
  • 4.2. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY PRODUCT
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION BY PRODUCT 2014-2022 ($ MILLION)
      • 4.2.5.1. PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS)
        • 4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
        • 4.2.5.1.3. APPLICATION
        • 4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
        • 4.2.5.1.6. KEY CONCLUSIONS
        • 4.2.5.1.7. SUB-SEGMENTS
          • 4.2.5.1.7.1. ENTERPRISE PACS
          • 4.2.5.1.7.2. DEPARTMENTAL PACS MARKET

4.2.5.1.7.2.1. CARDIOLOGY PACS

4.2.5.1.7.2.2. RADIOLOGY PACS

4.2.5.1.7.2.3. OTHER DEPARTMENTAL PACS

      • 4.2.5.2. VENDOR NEUTRAL ARCHIVES (VNA)
        • 4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
        • 4.2.5.2.3. APPLICATION
        • 4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
        • 4.2.5.2.6. KEY CONCLUSIONS
        • 4.2.5.2.7. SUB-SEGMENTS
          • 4.2.5.2.7.1. BY PROCUREMENT MODEL

4.2.5.2.7.1.1. MULTI-DEPARTMENTAL ENTERPRISE VNA

4.2.5.2.7.1.2. MULTI-SITE ENTERPRISE VNA

4.2.5.2.7.1.3. DEPARTMENTAL VNA

          • 4.2.5.2.7.2. BY DELIVERY MODEL

4.2.5.2.7.2.1. HYBRID VNA

4.2.5.2.7.2.2. ON-PREMISE

4.2.5.2.7.2.3. FULLY CLOUD-BASED VNA

      • 4.2.5.3. APPLICATION-INDEPENDENT CLINICAL ARCHIVE (AICA)
        • 4.2.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
        • 4.2.5.3.3. APPLICATION
        • 4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. REGIONAL ANALYSIS 2014-2022 ($ MILLION)
        • 4.2.5.3.6. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF M&A
    • 5.1.2. LIST OF JV
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY REGION 2014-2022 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. END USER ANALYSIS 2014-2022 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY END USER ANALYSIS 2014-2022 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. ITALY
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY END USER ANALYSIS 2014-2022 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. SOUTH KOREA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY END USER ANALYSIS 2014-2022 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2022 ($ MILLION)
          • 6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. AGFA-GEVAERT GROUP (AGFA)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
  • 7.2. ASHVA DIGITAL HEALTHCARE
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
  • 7.3. BRIDGEHEAD SOFTWARE
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
  • 7.4. CARESTREAM HEALTH INC.
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
  • 7.5. FUJIFILM HOLDINGS CORPORATION
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
  • 7.6. GENERAL ELECTRIC COMPANY
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
  • 7.7. HITACHI DATA SYSTEMS
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
  • 7.8. LUMEDX CORPORATION
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
  • 7.9. MCKESSON CORPORATION
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
  • 7.10. MERGE HEALTHCARE INC. (ACQUIRED BY IBM CORPORATION)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
  • 7.11. NOVARAD CORPORATION
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
  • 7.12. PHILIPS HEALTHCARE
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
  • 7.13. SIEMENS HEALTHCARE
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
  • 7.14. TELEMIS
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
  • 7.15. VITAL IMAGES INC.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS

LIST OF TABLES

  • 1. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY END USER 2014-2022 ($ MILLION)
  • 2. GLOBAL DIAGNOSTIC IMAGING CENTERS MEDICAL IMAGE MANAGEMENT BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 3. GLOBAL HOSPITALS MEDICAL IMAGE MANAGEMENT BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 4. GLOBAL OTHER END USERS MEDICAL IMAGE MANAGEMENT BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 5. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY PRODUCT 2014-2022 ($ MILLION)
  • 6. GLOBAL PICTURE ARCHIVING & COMMUNICATION SYSTEMS (PACS) MEDICAL IMAGE MANAGEMENT BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 7. GLOBAL VENDOR NEUTRAL ARCHIVES (VNA) MEDICAL IMAGE MANAGEMENT BY GEOGRAPHY 2014-2022 ($ MILLION)
  • 8. NORTH AMERICA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 9. EUROPE MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 10. ASIA PACIFIC MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 11. REST OF THE WORLD MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY DIAGNOSTIC IMAGING CENTERS 2014-2022 ($ MILLION)
  • 2. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY HOSPITALS 2014-2022 ($ MILLION)
  • 3. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY OTHER END USERS 2014-2022 ($ MILLION)
  • 4. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) 2014-2022 ($ MILLION)
  • 5. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY DEPARTMENTAL PACS 2014-2022 ($ MILLION)
  • 6. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY VENDOR NEUTRAL ARCHIVES (VNA) 2014-2022 ($ MILLION)
  • 7. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY PROCUREMENT MODEL 2014-2022 ($ MILLION)
  • 8. GLOBAL MEDICAL IMAGE MANAGEMENT MARKET BY DELIVERY MODEL 2014-2022 ($ MILLION)
  • 9. UNITED STATES (U.S.) MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 10. CANADA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 11. UNITED KINGDOM (UK) MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 12. FRANCE MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 13. GERMANY MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 14. SPAIN MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 15. ITALY MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 16. ROE MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 17. INDIA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 18. CHINA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 19. JAPAN MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 20. KOREA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 21. AUSTRALIA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 22. ROAPAC MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 23. LATIN AMERICA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
  • 24. MENA MEDICAL IMAGE MANAGEMENT MARKET 2014-2022 ($ MILLION)
Back to Top